JTK 656Alternative Names: JTK-656
Latest Information Update: 08 Dec 2011
At a glance
- Originator Japan Tobacco
- Class Antiretrovirals
- Mechanism of Action HIV integrase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 31 Oct 2011 Discontinued - Phase-I for HIV infections (PO)
- 30 Oct 2008 Phase-I clinical trials in HIV infections (PO)